Disease-modifying therapy in rheumatoid arthritis and changes in cytokine levels depending on genetic characteristics

Bukach, O.; Zrybnieva, K.; Kuzemko, I.; Popovych, A.

dc.contributor.author	Bukach, O.
dc.contributor.author	Zrybnieva, K.
dc.contributor.author	Kuzemko, I.
dc.contributor.author	Popovych, A.
dc.date.accessioned	2025-02-21T07:53:51Z
dc.date.available	2025-02-21T07:53:51Z
dc.date.issued	2023
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26210
dc.description.abstract	Abstract. Among the factors that influence the occurrence of rheumatoid arthritis, a complex interaction of genetic, environmental, immunological, hormonal, socio-economic and psychological prerequisites is noted. Genetic factors in interaction with the environment and an individual's lifestyle play an important role in changing gene expression and the clinical realization of inherited or acquired pathology, including multifactorial. That is why the study of genetic mutations and their association in patients with rheumatoid arthritis is important today not only from a scientific point of view, but also for practical health care.	uk_UA
dc.language.iso	en	uk_UA
dc.publisher	Slovak international scientific journal	uk_UA
dc.subject	rheumatoid arthritis	uk_UA
dc.subject	eNOS gene promoter T-786C polymorphism	uk_UA
dc.subject	disease-modifying therapy	uk_UA
dc.subject	cytokine profile	uk_UA
dc.title	Disease-modifying therapy in rheumatoid arthritis and changes in cytokine levels depending on genetic characteristics	uk_UA
dc.type	Article	uk_UA